The Association between Vision Impairment and Depression: A Systematic Review of Population-Based Studies
- PMID: 35566537
- PMCID: PMC9103717
- DOI: 10.3390/jcm11092412
The Association between Vision Impairment and Depression: A Systematic Review of Population-Based Studies
Abstract
We conducted a systematic review and meta-analysis to investigate whether depression is associated with vision impairment (VI) in population-based studies in adults. MEDLINE and EMBASE were searched, from inception to June 2020. Studies were included if they provided two-by-two data for calculating the OR of association between VI and depression, or crude and/or an adjusted odds ratio (OR) with a corresponding 95% confidence interval (CI) were reported. The proportion of VI and depression was also extracted. ORs were pooled using random-effect models, proportions were pooled using random intercepts logistic regression models. Overall, 29 articles (31 studies) were included: of those, 18 studies used survey data (622,312 participants), 10 used clinical examination data (69,178 participants), and 3 used administrative databases (48,162,290 participants). The proportion of depression (95%CI) was 0.17 (0.13-0.22) overall and 0.27 (0.21-0.33) in VI subjects. The proportion of VI was 0.10 (0.07-0.16) overall and 0.20 (0.13-0.29) in depressed subjects. The association between VI and depression was direct: crude ORs were 1.89 (1.51-2.37) for survey data, 2.17 (1.76-2.67) for clinical examination data, and 3.34 (1.01-11.11) for administrative databases; adjusted ORs were 1.75 (1.34-2.30), 1.59 (1.22-1.96), and 2.47 (0.97-6.33), respectively. In conclusion, VI and depression are prevalent morbidities and should be actively sought when either is identified, especially in older adults.
Keywords: blindness; depression; meta-analysis; systematic review; visual impairment.
Conflict of interest statement
The authors have no proprietary/financial interest regarding the publication of this study. G.V., D.P., E.M., S.P.M., and A.C. have nothing to disclose. M.P. reports personal fees from Allergan, Novartis, and Bayer outside the submitted research; F.M. reports personal fees from Novartis Pharma AG; P.L. is a consultant to Allergan, Bayer, Centervue, Novartis, Roche outside the submitted research; M.V. reports personal fees from Allergan, Novartis, and Bayer, Sifi outside the submitted research; E.L. reports personal fees from Angelini outside the submitted research.
Figures
References
-
- Ehrlich J.R., Ramke J., Macleod D., Burn H., Lee C.N., Zhang J.H., Waldock W., Swenor B.K., Gordon I., Congdon N., et al. Association between vision impairment and mortality: A systematic review and meta-analysis. Lancet Glob. Health. 2021;9:e418–e430. doi: 10.1016/S2214-109X(20)30549-0. - DOI - PMC - PubMed
-
- Tan B.K.J., Man R.E.K., Gan A.T.L., Fenwick E.K., Varadaraj V., Swenor B.K., Gupta P., Wong T.Y., Trevisan C., Lorenzo-López L., et al. Is Sensory Loss an Understudied Risk Factor for Frailty? A Systematic Review and Meta-analysis. J. Gerontol. A. Biol. Sci. Med. Sci. 2020;75:2461–2470. doi: 10.1093/gerona/glaa171. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
